| 000 | 01715 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514235902.0 | ||
| 264 | 0 | _c20051107 | |
| 008 | 200511s 0 0 eng d | ||
| 022 | _a1352-0504 | ||
| 024 | 7 |
_a10.1111/j.1365-2893.2005.00615.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTerrault, N A | |
| 245 | 0 | 0 |
_aClinical utility of viral load measurements in individuals with chronic hepatitis C infection on antiviral therapy. _h[electronic resource] |
| 260 |
_bJournal of viral hepatitis _cSep 2005 |
||
| 300 |
_a465-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepacivirus _xclassification |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 |
_aRNA, Viral _xblood |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aRibavirin _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aViral Load |
| 650 | 0 | 4 |
_aViremia _xdrug therapy |
| 700 | 1 | _aPawlotsky, J-M | |
| 700 | 1 | _aMcHutchison, J | |
| 700 | 1 | _aAnderson, F | |
| 700 | 1 | _aKrajden, M | |
| 700 | 1 | _aGordon, S | |
| 700 | 1 | _aZitron, I | |
| 700 | 1 | _aPerrillo, R | |
| 700 | 1 | _aGish, R | |
| 700 | 1 | _aHolodniy, M | |
| 700 | 1 | _aFriesenhahn, M | |
| 773 | 0 |
_tJournal of viral hepatitis _gvol. 12 _gno. 5 _gp. 465-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2893.2005.00615.x _zAvailable from publisher's website |
| 999 |
_c15745989 _d15745989 |
||